Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
Aryeh Fischer,1 Nina M Patel,2 Elizabeth R Volkmann3 1Division of Rheumatology, Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA; 2Division of Pulmonary, Allergy and Critical Care Medicine, Columbia Universi...
Enregistré dans:
Auteurs principaux: | Fischer A, Patel NM, Volkmann ER |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2c548f2fa33040cb9dc89b82735b64d3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
par: Amigues I, et autres
Publié: (2019) -
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
par: Byoung Soo Kwon, et autres
Publié: (2021) -
Rheumatoid arthritis-associated interstitial lung disease
par: Brown KK, et autres
Publié: (2012) -
Animal models of systemic sclerosis: their utility and limitations
par: Artlett CM
Publié: (2014) -
The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis
par: Bei Xu, et autres
Publié: (2021)